Literature DB >> 7272141

Primary pulmonary hypertension: effects of nifedipine.

J J Dalal, B E Griffiths, A H Henderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272141      PMCID: PMC482638          DOI: 10.1136/hrt.46.2.230

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  8 in total

1.  Diazoxide in primary pulmonary hypertension.

Authors:  W P Klinke; J A Gilbert
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

2.  Vasodilator therapy for pulmonary hypertension.

Authors:  L Cotter; M Honey
Journal:  N Engl J Med       Date:  1980-05-29       Impact factor: 91.245

3.  Haemodynamic effects of nifedipine in heart failure.

Authors:  S Klugmann; A Salvi; F Camerini
Journal:  Br Heart J       Date:  1980-04

4.  Diazoxide in treatment of primary pulmonary hypertension.

Authors:  S W Wang; J E Pohl; D J Rowlands; E G Wade
Journal:  Br Heart J       Date:  1978-05

5.  Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema.

Authors:  A Polese; C Fiorentini; M T Olivari; M D Guazzi
Journal:  Am J Med       Date:  1979-05       Impact factor: 4.965

6.  Oral hydralazine therapy for primary pulmonary hypertension.

Authors:  L J Rubin; R H Peter
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

7.  Primary pulmonary hypertension: effects of nifedipine.

Authors:  F Camerini; E Alberti; S Klugmann; A Salvi
Journal:  Br Heart J       Date:  1980-09

8.  Nifedipine and left ventricular function in beta-blocked patients.

Authors:  P I Joshi; J J Dalal; M S Ruttley; D J Sheridan; A H Henderson
Journal:  Br Heart J       Date:  1981-04
  8 in total
  2 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 2.  Drug treatment of primary pulmonary hypertension.

Authors:  A A McLeod; D E Jewitt
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.